Two other problems for CYP. The first , you are treating a large group that has a high responce rate so may be harder to show significants.
The second and probabley more significant is that you are going into the P2 without clinical evedence. Yes you have some P1 data but this is at a later stage. You may find that the patients havent got the most important markers that activate the cells.
CYP Price at posting:
30.5¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)